type here...

CATEGORIES

Press Release

LATEST

1...8910...12Page 9 of 12

TRENDING

EDITORS CHOICE

ACOG Statement on the Johnson & Johnson COVID-19 Vaccine

Medika Life -
ACOG issues a statement to its members on the temporary withdrawal of the Johnson & Johnson vaccine following reports of rare blood clotting condition.

Coronavirus: FDA Authorizes First Point-of-Care Antibody Test

Medika Life -
The Assure COVID-19 IgG/IgM Rapid Test Device is currently the only FDA authorized COVID-19 POC serology test and is available by prescription only.

Voluntary Recall: Two Lots of NP Thyroid® Tablets, Due to Sub Potency

Medika Life -
Acella Pharmaceuticals, LLC is voluntarily recalling one lot of 15-mg and one lot of 120-mg NP Thyroid®, Thyroid Tablets, USP [levothyroxine (T4) and liothyronine (T3)] to the consumer level.

SPRAVATO® (esketamine) CIII Nasal Spray to Treat Depressive Symptoms in Adults Approved

Medika Life -
SPRAVATO® (esketamine) CIII nasal spray, taken with an oral antidepressant, to treat depressive symptoms in adults with major depressive disorder (MDD) with acute suicidal ideation or behavior.

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories